A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

• Status: Withdrawn
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the effectiveness and safety of seletracetam when it is used in addition to other anti-epileptic medications by patients with partial onset seizures. It will also help to determine the best dose to use.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UCB Pharma

Criteria

Inclusion Criteria:

• Subjects from 16 to 70 years old

• Confirmed diagnosis of focal epilepsy

• Partial seizures uncontrolled while taking 1 or 2 AEDs

• At least 8 partial seizures during the 8-week baseline period

Exclusion Criteria:

• Seizures occurring only in clusters

• Status epilepticus within 1 year

• Progressive CNS disorder

• Other serious or uncontrolled diseases